EyePoint, Inc. last reported quarterly results on Oct 19, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026). It usually reports 7–36 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 6, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Jan 7, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 7–36 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 19, 2026
19 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
—
|
—
|
—
|
|
Aug 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
1
-90.5%
|
-94
-59.0%
|
-1.09
-28.2%
|
|
May 6, 2026
36 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1
-97.2%
|
-85
-87.7%
|
-0.99
-52.3%
|
|
Jan 7, 2026
7 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
1
-94.6%
|
-68
-63.3%
|
-814.61
-27.0%
|
|
Oct 14, 2025
14 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1
-90.8%
|
-60
-103.4%
|
-0.85
-57.4%
|
|
Aug 6, 2025
37 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
5
-43.7%
|
-59
-92.8%
|
-0.85
-46.6%
|
|
May 7, 2025
37 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
24
+109.3%
|
-45
-54.3%
|
-0.65
-18.2%
|
|
Jan 13, 2025
13 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
12
-17.4%
|
-41
-193.6%
|
-641.61
-508029.2%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- EYPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1314102
- Former names
- EyePoint Pharmaceuticals, Inc. (until Dec 8, 2025); pSivida Corp. (until Mar 30, 2018); pSivida LTD (until Jun 18, 2008)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.